One example of the explanatory potential of the extended gene is seen for the splicing factor SRSF2, which has been shown to affect liver cancer progression and for which differential expression in HepG2 can be well predicted using mutations in the extended gene (Fig. 5a, p-value = 0.002, one-sided Wilcoxon test). The gene discussed is SRSF2; the disease is liver cancer.